Press Release
Graeme Thickins
Communications Specialist
Public Relations Manager
Microsoft Word
Silk Technologies
https://www.prweb.com/releases/silktech_biopharmaceuticals_ind_submission_cleared_by_fda_phase_2_clinical_trial_initiated_for_patients_with_dry_eye_disease/prweb16242674.htm
2019
